Novo Nordisk A/S ADR (NY: NVO )

105.06 +2.43 (+2.37%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form 6-K
Source: SEC/Edgar
October 03, 2017
Form 6-K
Source: SEC/Edgar
October 01, 2017
Form 6-K
Source: SEC/Edgar
September 28, 2017
Form 6-K
Source: SEC/Edgar
September 28, 2017
Form 6-K
Source: SEC/Edgar
September 25, 2017
Form 6-K
Source: SEC/Edgar
September 10, 2017
Form 6-K
Source: SEC/Edgar
September 04, 2017
Form 6-K
Source: SEC/Edgar
August 27, 2017
Form 6-K
Source: SEC/Edgar
August 27, 2017
Form 6-K
Source: SEC/Edgar
August 21, 2017
Form 6-K
Source: SEC/Edgar
August 17, 2017
Form 6-K
Source: SEC/Edgar
August 14, 2017
Form 6-K
Source: SEC/Edgar
August 13, 2017
Form 6-K
Source: SEC/Edgar
August 13, 2017
Form 6-K
Source: SEC/Edgar
August 09, 2017
Form 6-K
Source: SEC/Edgar
August 09, 2017
Form 6-K
Source: SEC/Edgar
August 07, 2017
Form 6-K
Source: SEC/Edgar
August 01, 2017
Form 6-K
Source: SEC/Edgar
July 27, 2017
Form 6-K
Source: SEC/Edgar
July 23, 2017
Form 6-K
Source: SEC/Edgar
July 16, 2017
Form 11-K
Source: SEC/Edgar
July 10, 2017
Form 6-K
Source: SEC/Edgar
July 10, 2017
Form 6-K
Source: SEC/Edgar
July 02, 2017
Form 11-K
Source: SEC/Edgar
July 02, 2017
Form 6-K
Source: SEC/Edgar
July 02, 2017
Form 11-K
Source: SEC/Edgar
June 27, 2017
Form SD
Source: SEC/Edgar
May 30, 2017
Form 6-K
Source: SEC/Edgar
May 16, 2017
Form 6-K
Source: SEC/Edgar
April 24, 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.